Synthace Ltd. the company behind the leading cloud software platform for automating and improving the success rate of biological research and development, today announced that it has become the latest life sciences company to sign with Stanhope, Mitsui Fudosan and AIMCo. The bioscience company will take 13,000 square feet on the fourth floor of the WestWorks building at White City Place.

The announcement follows the news that NASDAQ listed biopharmaceutical company Autolus has chosen to relocate to White City Place, and consolidates its reputation as a new hub for life science companies anchored by Imperial College’s White City campus in West London. Moving from their current location in St Pancras, Synthace will initially move 40 people to the site, rising to 80 within a year as the company’s growth accelerates.

A leader in Computer-Aided Biology, Synthace’s cloud software enables life science companies to realise their Lab of the Future ambitions, where automation and AI combine to drive vast improvements in the speed, cost and reliability of developing biotechnology.

In 2016 Synthace was selected as one of the world’s 30 most promising Technology Pioneers by the World Economic Forum and in 2018 was selected as a Gartner ‘Cool Vendor in Life-Sciences’. Following a £7.3 M Series-A round in September 2017, the company has doubled in size and appointed Silicon Valley Veteran Bob Wiederhold as its Chairman.